Join us for "Methodological Borrowing versus Conceptual Blending: Reengineering Health Economics Processes with Modeling and Simulations," Featuring PRECISIONheor's Ross Maclean and Anuj Mubayi.
Did you miss PRECISIONheor at Virtual ISPOR 2021? Find out more about what was presented at the conference and download our available posters here.
Congratulations to PRECISIONheor’s Meaghan Roach MPH, Caroline Huber MPH, Suepattra May-Slater MPH, PhD, and Isha Desai MPH on the successful presentation of their poster "A Qualitative Study Describing Oncology Practitioners’ Approaches to First-Line (1L) Treatment of Metastatic Urothelial Cancer (mUC) in the United States" at NCCN 2021.
Congratulations to PRECISIONadvisors and PRECISIONheor for presenting more than a dozen posters and panels at Virtual ISPOR Europe 2020, 16 - 19 November, 2020.
Congratulations to Precision Medicine Group Co-Founder and CEO Mark Clein on his moderated Point: Counterpoint panel at this year’s HLTH Conference.
Moderated by Precision's Ross Maclean, our distinguished panel of experts provide key insights on why social determinants of health (SDOH) are critical factors to inform today's treatment planning, care delivery, health policy, health outcomes and value.
Expanding traditional value frameworks to include inequality and factors that contribute to this is the first step to addressing disparities in health outcomes.
Precision is excited to welcome Hema Viswanathan as Vice President, PRECISIONheor. With more than 15 years experience in the industry, Hema brings exceptional insights and strategic vision. Hema will support cross functions in health economics and outcomes research (HEOR) from RWE, Evidence Synthesis and Modeling. Welcome to the Precision team!
Precision is excited to be headed to Copenhagen, November 2nd - 6th! Be sure to catch our scientific presentations at the conference, and meet our experts!
Meet our subject matter experts to hear how we can support you with health technology assessments, new models for evidence synthesis, and defending the value of your treatments to payers.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
